Jaktinib (JAK1/2 inhibitor): A momelotinib derivative with similar activity and optimized dosing schedule.
作者信息
Tefferi Ayalew, Gangat Naseema, Pardanani Animesh
机构信息
Divisions of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
出版信息
Am J Hematol. 2022 Dec;97(12):1507-1509. doi: 10.1002/ajh.26712. Epub 2022 Sep 15.
PMID:36057765
Abstract
摘要
Zotero 插件